Patents by Inventor Maria Torres
Maria Torres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240150850Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.Type: ApplicationFiled: June 9, 2023Publication date: May 9, 2024Inventors: Maria Torres-Gonzalez, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler
-
Publication number: 20240092028Abstract: In some examples, a system applies a first adjustment factor to a first representation of a first lattice structure of a first three-dimensional (3D) part to generate a first adjusted representation of the first lattice structure, the first representation comprising a representation of beams of the first lattice structure without a thickness. The system applies a second adjustment factor to a second representation of a second lattice structure of a second 3D part to generate a second adjusted representation of the second lattice structure, the second representation comprising a representation of beams of the second lattice structure without a thickness. The system adds beam thicknesses to the first and second adjusted representation to provide respective digital models of the first and second 3D parts that are useable by an additive manufacturing machine in building the first and second 3D parts in respective build regions of a build bed.Type: ApplicationFiled: September 20, 2022Publication date: March 21, 2024Inventors: Marc Casalprim Torres, Alberto María Canals Pou
-
Publication number: 20240067848Abstract: An adhesive label is described comprising a backing material, a pressure-sensitive adhesive layer attached to the backing material and either a release liner attached to the adhesive layer or a release coating on the other side of the backing material. The backing material is made of paper or home compostable and biodegradable polymer film, and the pressure-sensitive adhesive layer is made from an aqueous polyurethane dispersion pressure-sensitive adhesive. At least 60% by weight of the polyurethane is composed of diisocyanates, polyesterdiols, and at least one bifunctional carboxylic acid selected from di hydroxy carboxylic acids and diamino carboxylic acids, wherein the polyurethane has no melting point above 20° C. or wherein the polyurethane has a melting point above 20° C. with an enthalpy of fusion lower than 10 J/g, and wherein a film of the polyurethane adhesive preferably decomposes at home compost conditions to more than 90% by weight into CO2 and water within 360 days.Type: ApplicationFiled: February 16, 2022Publication date: February 29, 2024Inventors: Paul ACHATZ, Jeremy Jon SLOAN, Jose Maria TORRES LLOSA, Ulrike LICHT
-
Patent number: 11708614Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.Type: GrantFiled: June 15, 2017Date of Patent: July 25, 2023Assignees: STRECK LLC, CREIGHTON UNIVERSITYInventors: Maria Torres-Gonzalez, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler
-
Publication number: 20190330685Abstract: Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple ?-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and/or probes for identification of ?-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT/MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24/40-like, TEM-like, and SHV-like. A kit may also include one or more primers and/or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.Type: ApplicationFiled: June 15, 2017Publication date: October 31, 2019Inventors: Maria Torres, Nancy Hanson, Joel Lechner, Stephanie Cossette, Cathy Scheer, Matthew R. Kreifels, Stacey Morrow, Christopher Connelly, Laura R. Porter, Randy Fowler
-
Patent number: 9757349Abstract: Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic compound that enters the cells of the proximal tubule through cholesterol rafts. The invention is based on the discovery that a great number of nephrotoxic compounds, including drugs, enter the cells of the proximal tubule through the cholesterol rafts, and that cilastatin is able to interfere with this transport mechanism, decreasing the nephrotoxicity of such compounds to a variable extent. The nephroprotective effect is common to compounds of different chemical nature and solubility and is specific for the kidney, causing no interference with the effects of nephrotoxic drugs having their targets in other organs. Therefore, administration of cilastatin allows for decreasing the nephrotoxic effects of different drugs without reducing their therapeutic effects.Type: GrantFiled: August 10, 2016Date of Patent: September 12, 2017Assignee: FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANONInventors: Alberto Tejedor Jorge, Alberto Lazaro Fernandez, Sonia Camano Paez, Ana Maria Torres Redondo, Jose Antonio Lazaro Manero, Manuela Castilla Barba, Maria del Carmen De Lucas Collantes
-
Publication number: 20170205154Abstract: The heat and mass exchange module comprises a plurality of sheets in a spaced-apart arrangement with a plurality of air channels for air flow and a plurality of liquid channels for flow of liquid desiccant material. A liquid channel has a layer of wicking material on a sheet and is arranged adjacent to an air channel with a mutual exchange surface, which liquid channel is provided with an entry and an exit and which air channel is provided with an inlet and an outlet. In the cross-flow module the plurality of air channels extend in a first flow direction from inlet to outlet and the plurality of liquid channels extend in a second flow direction from entry to exit, which second flow direction is different from the first flow direction. The exchange surface is substantially planar along the first flow direction, but is non-planar along the second flow direction.Type: ApplicationFiled: September 30, 2015Publication date: July 20, 2017Inventors: Federico Maria TORRE LA, Jan Paul Annie ROOSEN, Robertus Wilhelmus Jacobus HOLLENRING
-
Publication number: 20170035718Abstract: Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic compound that enters the cells of the proximal tubule through cholesterol rafts. The invention is based on the discovery that a great number of nephrotoxic compounds, including drugs, enter the cells of the proximal tubule through the cholesterol rafts, and that cilastatin is able to interfere with this transport mechanism, decreasing the nephrotoxicity of such compounds to a variable extent. The nephroprotective effect is common to compounds of different chemical nature and solubility and is specific for the kidney, causing no interference with the effects of nephrotoxic drugs having their targets in other organs. Therefore, administration of cilastatin allows for decreasing the nephrotoxic effects of different drugs without reducing their therapeutic effects.Type: ApplicationFiled: August 10, 2016Publication date: February 9, 2017Inventors: Alberto TEJEDOR JORGE, Alberto LAZARO FERNANDEZ, Sonia CAMANO PAEZ, Ana Maria TORRES REDONDO, Jose Antonio LAZARO MANERO, Manuela CASTILLA BARBA, Maria del Carmen DE LUCAS COLLANTES
-
Patent number: 9522128Abstract: Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic compound that enters the cells of the proximal tubule through cholesterol rafts. The invention is based on the discovery that a great number of nephrotoxic compounds, including drugs, enter the cells of the proximal tubule through the cholesterol rafts, and that cilastatin is able to interfere with this transport mechanism, decreasing the nephrotoxicity of such compounds to a variable extent. The nephroprotective effect is common to compounds of different chemical nature and solubility and is specific for the kidney, causing no interference with the effects of nephrotoxic drugs having their targets in other organs. Therefore, administration of cilastatin allows for decreasing the nephrotoxic effects of different drugs without reducing their therapeutic effects.Type: GrantFiled: November 13, 2015Date of Patent: December 20, 2016Assignee: Fundacion Para La Investigacion Biomedica Del Hospital Gregorio MaranonInventors: Alberto Tejedor Jorge, Alberto Lazaro Fernandez, Sonia Camano Paez, Ana Maria Torres Redondo, Jose Antonio Lazaro Manero, Manuela Castilla Barba, Maria del Carmen De Lucas Collantes
-
Publication number: 20160136121Abstract: Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic compound that enters the cells of the proximal tubule through cholesterol rafts. The invention is based on the discovery that a great number of nephrotoxic compounds, including drugs, enter the cells of the proximal tubule through the cholesterol rafts, and that cilastatin is able to interfere with this transport mechanism, decreasing the nephrotoxicity of such compounds to a variable extent. The nephroprotective effect is common to compounds of different chemical nature and solubility and is specific for the kidney, causing no interference with the effects of nephrotoxic drugs having their targets in other organs. Therefore, administration of cilastatin allows for decreasing the nephrotoxic effects of different drugs without reducing their therapeutic effects.Type: ApplicationFiled: November 13, 2015Publication date: May 19, 2016Inventors: Alberto TEJEDOR JORGE, Alberto LAZARO FERNANDEZ, Sonia CAMANO PAEZ, Ana Maria TORRES REDONDO, Jose Antonio LAZARO MANERO, Manuela CASTILLA BARBA, Maria del Carmen DE LUCAS COLLANTES
-
Patent number: 9216185Abstract: Use of cilastatin to reduce the nephrotoxicity of different compounds. The invention refers to use of cilastatin to prepare a medicinal product to reduce the nephrotoxicity of a nephrotoxic compound that enters the cells of the proximal tubule through cholesterol rafts. The invention is based on the discovery that a great number of nephrotoxic compounds, including drugs, enter the cells of the proximal tubule through the cholesterol rafts, and that cilastatin is able to interfere with this transport mechanism, decreasing the nephrotoxicity of such compounds to a variable extent. The nephroprotective effect is common to compounds of different chemical nature and solubility and is specific for the kidney, causing no interference with the effects of nephrotoxic drugs having their targets in other organs. Therefore, administration of cilastatin allows for decreasing the nephrotoxic effects of different drugs without reducing their therapeutic effects.Type: GrantFiled: July 11, 2008Date of Patent: December 22, 2015Assignee: Fundacion Para La Investigacion Biomedica Del Hospital Gregorio MaranonInventors: Alberto Tejedor Jorge, Alberto Lazaro Fernandez, Sonia Camaño Paez, Ana Maria Torres Redondo, José Antonio Lazaro Manero, Manuela Castilla Barba, María del Carmen De Lucas Collantes
-
Patent number: 9018558Abstract: The disclosure relates to a gas circuit breaker switch (5) which can be integrated inside a switching device insulated in a dielectric gas, said switch (5) comprising an arc chute (1) inside which a fixed contact (3) and a moving contact (4) are arranged. The integration of the contacts (3, 4) inside at least one casing (19, 20) corresponding to the arc chute (1) allows reducing distances between phases, in addition to preventing any incident in one phase from affecting the remaining phases, and finally more compact electrical equipment is obtained. The switch (5) also comprises at least one generation means (6) for generating at least one gas, at least one blowout/intake means (7) for at least one extinguishing gas and at least one generation means (2) for generating a magnetic field, such that the electric arc generated between the contacts (3, 4) of the switch (5) can be extinguished by combining said means (6, 7, 2).Type: GrantFiled: May 31, 2010Date of Patent: April 28, 2015Assignee: Ormazabal Y CIA, S.L.Inventors: Norberto Sainz de la Maza Escobal, Juan María Casado Cartón, José Manuel Inchausti Sancho, José María Torres Novalbos
-
Patent number: 8989357Abstract: A method and an inference engine for processing telephone communication data of telephone parties of a telephone network are provided to allow better services and better allocation of resources in a telephone network. The inference engine comprises an obtainer for obtaining telephone communication data that associates telephone parties identifiable by telephone network identifiers with usage data that describes usage of one or more services of a telephone network. Further, the inference engine also comprises a generator for generating contact structure data for a set of the telephone parties based on the telephone communication data, wherein the contact structure data expresses a degree of connectivity between each member of at least a part of the set and one or more other members. The generated data gives the required information to improve services and resource allocation in the network.Type: GrantFiled: March 12, 2008Date of Patent: March 24, 2015Assignee: Telefonaktiebolaget L M Ericsson (publ)Inventors: Jesus Renero Quintero, Javier Maria Torres Ramon, Luis Osa Gomez Del Campo
-
Patent number: 8987163Abstract: Disclosed is a process for the production of lower olefins by the conversion of a feed stream comprising carbon monoxide and hydrogen, and catalysts as used therein, such as a Fischer-Tropsch process. By virtue of the invention, lower olefins can be formed from synthesis gas, with high selectivity, and low production of methane. The catalysts used herein comprise an ?-alumina support, and a catalytically active component that comprises iron-containing particles dispersed onto the support in at least 1 wt. %. The majority of the iron-containing particles is in direct contact with the ?-alumina and is well-distributed thereon. Preferably, the iron-containing particles have an average particle size below 30 nm, and most preferably below 10 nm. The supported catalysts not only show a high selectivity, but also a high catalyst activity and chemical and mechanical stability.Type: GrantFiled: March 12, 2014Date of Patent: March 24, 2015Assignee: Nederlandse organisatie voor wetenschappelijk onderzoek (NWO)Inventors: Hirsa Maria Torres Galvis, Johannes Hendrik Bitter, Krijn Pieter de Jong
-
Publication number: 20140256542Abstract: Disclosed is a process for the production of lower olefins by the conversion of a feed stream comprising carbon monoxide and hydrogen, and catalysts as used therein, such as a Fischer-Tropsch process. By virtue of the invention, lower olefins can be formed from synthesis gas, with high selectivity, and low production of methane. The catalysts used herein comprise an ?-alumina support, and a catalytically active component that comprises iron-containing particles dispersed onto the support in at least 1 wt. %. The majority of the iron-containing particles is in direct contact with the ?-alumina and is well-distributed thereon. Preferably, the iron-containing particles have an average particle size below 30 nm, and most preferably below 10 nm. The supported catalysts not only show a high selectivity, but also a high catalyst activity and chemical and mechanical stability.Type: ApplicationFiled: March 12, 2014Publication date: September 11, 2014Inventors: Hirsa Maria Torres Galvis, Johannes Hendrik Bitter, Krijn Pieter de Jong
-
Patent number: 8703830Abstract: Disclosed is a process for the production of lower olefins by the conversion of a feed stream comprising carbon monoxide and hydrogen, and catalysts as used therein, such as a Fischer-Tropsch process. By virtue of the invention, lower olefins can be formed from synthesis gas, with high selectivity, and low production of methane. The catalysts used herein comprise an ?-alumina support, and a catalytically active component that comprises iron-containing particles dispersed onto the support in at least 1 wt. %. The majority of the iron-containing particles is in direct contact with the ?-alumina and is well-distributed thereon. Preferably, the iron-containing particles have an average particle size below 30 nm, and most preferably below 10 nm. The supported catalysts not only show a high selectivity, but also a high catalyst activity and chemical and mechanical stability.Type: GrantFiled: October 25, 2010Date of Patent: April 22, 2014Assignee: Netherlands Organisation for Scientific Research (Advanced Chemical Technologies for Sustainability)Inventors: Hirsa Maria Torres Galvis, Johannes Hendrik Bitter, Krijn Pieter de Jong
-
Patent number: 8670346Abstract: Apparatus for performing packet classification of data packets belonging to a packet flow through a packet data network. The apparatus comprises an ingress interface for receiving packets of said packet flow, and an active filter for disturbing one or more of said packets or for otherwise disturbing a characteristic of said flow. An egress interface is provided for sending the packets including a disturbance towards a destination. A monitor is also provided for monitoring said packet flow and/or one or more associated packet flows received by the apparatus to detect subsequent reactions in the flow/s to the disturbance, while a flow classifier is provided for attempting to classify the flow into one of a set of defined classes according to a detected reaction.Type: GrantFiled: November 27, 2009Date of Patent: March 11, 2014Assignee: Telefonaktiebolaget L M Ericsson (Publ)Inventors: Javier Maria Torres Ramon, Dimitrios Christodoulou, Luis Maria Lafuente Alvarez, David Manzano Macho
-
Patent number: 8527119Abstract: An optimization method and device for a take-off procedure of an aircraft. The device (1) comprising means (2, 10) for determining optimum values for take-off parameters and adapting them for the actual take-off conditions.Type: GrantFiled: August 31, 2010Date of Patent: September 3, 2013Assignee: Airbus Operations (SAS)Inventors: Jérôme Chaptal, Rosa Maria Torres Calderon
-
Publication number: 20130062313Abstract: The disclosure relates to a gas circuit breaker switch (5) which can be integrated inside a switching device insulated in a dielectric gas, said switch (5) comprising an arc chute (1) inside which a fixed contact (3) and a moving contact (4) are arranged. The integration of the contacts (3, 4) inside at least one casing (19, 20) corresponding to the arc chute (1) allows reducing distances between phases, in addition to preventing any incident in one phase from affecting the remaining phases, and finally more compact electrical equipment is obtained. The switch (5) also comprises at least one generation means (6) for generating at least one gas, at least one blowout/intake means (7) for at least one extinguishing gas and at least one generation means (2) for generating a magnetic field, such that the electric arc generated between the contacts (3, 4) of the switch (5) can be extinguished by combining said means (6, 7, 2).Type: ApplicationFiled: May 31, 2010Publication date: March 14, 2013Inventors: Norberto Sainz De La Maza Escobal, Juan María Casado Cartón, José Manuel Inchausti Sancho, José María Torres Novalbos
-
Publication number: 20120259026Abstract: Disclosed is a process for the production of lower olefins by the conversion of a feed stream comprising carbon monoxide and hydrogen, and catalysts as used therein, such as a Fischer-Tropsch process. By virtue of the invention, lower olefins can be formed from synthesis gas, with high selectivity, and low production of methane. The catalysts used herein comprise an ?-alumina support, and a catalytically active component that comprises iron-containing particles dispersed onto the support in at least 1 wt. %. The majority of the iron-containing particles is in direct contact with the ?-alumina and is well-distributed thereon. Preferably, the iron-containing particles have an average particle size below 30 nm, and most preferably below 10 nm. The supported catalysts not only show a high selectivity, but also a high catalyst activity and chemical and mechanical stability.Type: ApplicationFiled: October 25, 2010Publication date: October 11, 2012Inventors: Hirsa Maria Torres Galvis, Johannes Hendrik Bitter, Krijn Pieter de Jong